EMEA-001640-PIP01-14-M06
Key facts
Invented name |
Symkevi
|
Active substance |
|
Therapeutic area |
Pneumology-allergology
|
Decision number |
P/0406/2021
|
PIP number |
EMEA-001640-PIP01-14-M06
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of cystic fibrosis
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Vertex Pharmaceuticals (Ireland) Limited
E-mail: medicalinfo@vrtx.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|